"Bellingham Asthma, Allergy & Immunology Clinic provides independent asthma and allergy care to children and adults in Northwest Washington for over 30 years. We provide state-of-the-art evaluation and treatment of respiratory and allergic disease including asthma, nose and sinus allergies, pollen and pet allergies, food allergy, medication allergy, hives and swelling, chronic cough, eczema and skin allergy, and frequent infection. Our providers and office staff endeavor to provide the same quality and compassionate care that they would want for their own families. Call us today to schedule a consultation!"

During the past decade, Bellingham Asthma, Allergy & Immunology Clinic conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 8 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bellingham Asthma, Allergy & Immunology Clinic" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Allergy Therapeutics" with 2 trials sponsored, "Bio Products Laboratory" with 2 trials sponsored, "Optinose US Inc." with 2 trials sponsored and "Sunovion" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bellingham Asthma, Allergy & Immunology Clinic" #1 collaborator was "Atlantic Research Group" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Bellingham Asthma, Allergy & Immunology Clinic" are "Asthma" (4 trials), "Chronic Rhinosinusitis" (2 trials), "Common Variable Immunodeficiency" (2 trials), "Primary Immune Deficiency Disorders" (2 trials) and "Type I Hypersensitivity" (2 trials). Many other conditions were trialed in "Bellingham Asthma, Allergy & Immunology Clinic" in a lesser frequency.

Most popular intervention types in "Bellingham Asthma, Allergy & Immunology Clinic" are "Drug" (13 trials) and "Biological" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Lebrikizumab" (2 trials), "BAY1817080" (1 trials), "BLU-5937" (1 trials) and "Bradanicline" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bellingham Asthma, Allergy & Immunology Clinic" are 19 trials for "All" genders.

Currently, there are NaN active trials in "Bellingham Asthma, Allergy & Immunology Clinic". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Bellingham Asthma, Allergy & Immunology Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Bellingham Asthma, Allergy & Immunology Clinic, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".